Eli Lilly stock is having a moment, but the company could easily continue soaring.…
…
Bank of America analysts raise Eli Lilly price target amid obesity drug optimism…
Here are Fridays biggest calls on Wall Street.…
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Viking Therapeutics’ stock more than doubled on Tuesday following the release of trials results suggesting its injectable obesity treatment outperforms…
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but its coming.…
Zealand Pharma, Eli Lilly show the potential of treating liver disease with weight loss drugs, while the Change Healthcare outage…
A pharma giant and a gas stock were in focus among early analyst calls on Tuesday.…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter &…
CNBCs Jim Cramer on Monday said Eli Lilly, Berkshire Hathaway, Tesla and Broadcom have a chance to break the $1…
Zealand Pharmas Phase 2 trial was an "uniquivocal win" for a drug that can treat both liver disease and obesity,…
Why would Eli Lilly put on a failure party?…
…
Shares of Eli Lilly have risen by roughly 1,190% over the past 10 years.…
Eli Lilly is home to many blockbuster drugs including Mounjaro, Jardiance, Zepbound, and more.…
Eli Lillys hottest treatment might be Mounjaro, but the company has a lot more at its disposal.…
…
Eli Lillys hottest treatment might be Mounjaro, but the company has a lot more at its disposal.…
…
Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost…
Nvidia (NVDA), Eli Lilly (LLY), Meta Platforms (META), Uber Technologies (UBER) and Ralph Lauren (RL) are the five best-performing stocks…
The stock will still be crushing the market in all likelihood.…
The stock will still be crushing the market in all likelihood.…
…
Eli Lilly, Novo Nordisk get growth stock status on weight-loss drug boost…
Eli Lillys diabesity medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap,…
Weight loss drugs like Novo Nordisks Wegovy and Eli Lillys Zepbound cost over $1,000 a month, and right now, most…
Here are Fridays biggest calls on Wall Street.…
…
PALM BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous reports indicate…
The rollout of Alzheimers treatment Leqembi from Biogen is going slower than expected, providing a read-through for Club stock Eli…
It faces both clinical and competitive barriers, but they might not matter.…
…
…
Theres more for investors to get excited about in the biopharma world than just weight-loss drugs.…
NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat das Kursziel für Eli Lilly nach…
Eli Lilly shares stock target raised to $853 by Jefferies…
…
Everyone is excited about Zepbound, from patients to investors...…
Everyone is excited about Zepbound, from patients to investors...…
All three of these stocks are worth owning. But how do you start a position when they are rallying?…
Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years.…
Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize…
The pharmaceutical giant is gaining momentum, and investors are excited.…
After standout 2023 performances, Eli Lilly and Nvidia are red hot to start 2024, leaving shareholders with a high-class problem:…
Eli Lillys valuation is approaching $700 billion.…
Eli Lillys valuation is approaching $700 billion.…
Eli Lilly (LLY) and AstraZeneca (AZN) announce fourth-quarter results. Novo Nordisk (NVO), Merck (MRK) and Novartis (NVS) make M&A announcements.…
Investors are still excited about obesity treatments and weight-management drugs.…